EE495 Threshold Price in the US to Achieve Cost-Effective Use of Molnupiravir and PF-07321332/Ritonavir for the Prevention of Severe COVID-19 in High-Risk Adults
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.742
https://www.valueinhealthjournal.com/article/S1098-3015(22)00943-3/fulltext
Title :
EE495 Threshold Price in the US to Achieve Cost-Effective Use of Molnupiravir and PF-07321332/Ritonavir for the Prevention of Severe COVID-19 in High-Risk Adults
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00943-3&doi=10.1016/j.jval.2022.04.742
First page :
Section Title :
Open access? :
No
Section Order :
10666